Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0
Sign in

8c7c9bb7-76e0-480c-a0de-bbf48fa398f4

0f3b1dd4-3a02-544c-aacc-f332576123d4

Score in workbench →

Clinical attributes

From the source cohort, normalized into canonical keys plus the project's native columns.

cancer_type
cancer_type_detailed
subtype

GSVA pathway preview (50 Hallmark scores)

MeasuredDerivedReference

Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.

Top 10 elevated

  • PROTEIN_SECRETION+0.300
  • CHOLESTEROL_HOMEOSTASIS+0.100
  • DNA_REPAIR+0.100
  • HEME_METABOLISM+0.100
  • PEROXISOME+0.100
  • UNFOLDED_PROTEIN_RESPONSE+0.100
  • ANDROGEN_RESPONSE+0.000
  • BILE_ACID_METABOLISM+0.000
  • FATTY_ACID_METABOLISM+0.000
  • GLYCOLYSIS+0.000

Top 10 suppressed

  • ALLOGRAFT_REJECTION-0.600
  • INFLAMMATORY_RESPONSE-0.500
  • EPITHELIAL_MESENCHYMAL_TRANSITION-0.400
  • IL6_JAK_STAT3_SIGNALING-0.400
  • INTERFERON_GAMMA_RESPONSE-0.400
  • KRAS_SIGNALING_UP-0.400
  • REACTIVE_OXYGEN_SPECIES_PATHWAY-0.400
  • APICAL_JUNCTION-0.300
  • E2F_TARGETS-0.300
  • IL2_STAT5_SIGNALING-0.300

Patient twins — nearest pathway neighbors

MeasuredDerived

10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.

6 twins match this tumor's tissue · 4 come from a different tissue of origin

#SampleCancer typeSubtypecos similarity
1SRR1322163
brain-umap@2
GTEX0.864
2MBCProject_0343_T1_RNA
breast-umap@18
B0.857
3TCGA-A7-A0DC-01A-11R-A00Z-07
breast-umap@18
D0.848
4TCGA-G2-A3VY-01A-11R-A22U-07
bladder-landscape@3
0.846
5SRR612419
brain-umap@2
GTEX0.845
6MDT-AP-0119
medullo-epn-umap@date-based
MedMedulloblastoma0.845
7aMVAC.P_001_TURBT_S217
bladder-landscape@3
0.843
8TCGA-D8-A1XC-01A-11R-A14D-07
breast-umap@18
B0.843
9SRR1442356
brain-umap@2
GTEX0.841
10SRR29022828
breast-umap@18
B0.841

Per-pathway drug coverage

ModeledCalibratedDerived

For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.

0 of 6 elevated pathways have at least one drug that meaningfully reverses them.

Pathway (elevated)tumor scoreBest drugreversal magnitude
PROTEIN_SECRETION0.300Remibrutinib— uncovered
CHOLESTEROL_HOMEOSTASIS0.100Remibrutinib— uncovered
DNA_REPAIR0.100Idelalisib— uncovered
HEME_METABOLISM0.100Temsirolimus— uncovered
PEROXISOME0.100Idelalisib— uncovered
UNFOLDED_PROTEIN_RESPONSE0.100Idelalisib— uncovered